Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer

Clinical trial NCT05842525 · UNKNOWN

Trial details

NCT number: NCT05842525
Sponsor: Hunan Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2023-10-01
Primary completion: 2024-05-28
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.